A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health
  • Bristol-Myers Squibb

This publication has 40 references indexed in Scilit: